SlideShare a Scribd company logo
Zurich, Switzerland
PRELIMINARY PROGRAM
General Information
Date
25 – 26 October 2024
Venue
Hilton Zurich Airport
Hohenbuehlstrasse 10
8152 Opfikon
Switzerland
Learning objectives
Understanding the disease forms the basis,
being familiar with the treatment options
available, enlarges the armamentarium and
being able to implement them into clinical
practice provides the freedom and the
flexibility to offer sustainable personalized
solutions to treat patients with acute and
chronic aortic pathology in an aortic team.
During the CBL Seminar in Zurich, you will
be taken on an intensive expert interaction
journey through treatment concept of
defined locations of the organ Aorta by
addressing both open surgery and
endovascular therapy.
Course Directors
Martin Czerny, Freiburg, Germany
Jürg Schmidli, Bern, Switzerland
Seminar by
Aortic Association
www.aorticassociation.org
E-Mail: info@aorticassociation.com
Logistics and Organization
Education Event Impact GmbH
www.ee-impact.org
Tel.: +41 79 247 98 75
E-Mail: info@ee-impact.org
Program Friday, 25th
October 2024
Registration and Welcome Coffee
08:15 - 08:25 Introduction, Course Targets
Martin Czerny (Freiburg),
Jürg Schmidli (Bern)
08:25 –09:35
CASE 1: Sinus of Valsalva Aneurysm- Bicuspid Aortic Valve Aortopathy, Diameter at
Brachiocephalic Trunk 43mm, Small PAU-Like Structure in Zone 3, Regular Findings in
Downstream Segments
Chair: Martin Czerny (Freiburg), Jürg Schmidli (Bern)
CommitteeExperts: Joseph E. Bavaria (Philadelphia), Matthias Siepe (Bern)
08:25 - 08:35 Case Presentation Robin Heijmen (Nijmegen)
08:35 - 08:40 Imaging Analysis Adrian Huber (Lucerne)
08:40 - 08:45 Guideline Comment Alessandro Della Corte (Naples)
08:45 - 08:50 Q&A, Voting and Discussion All
08:50 - 08:55 Clinical and R&D Representative Solution 1 TBA
08:55 - 09:00 Clinical and R&D Representative Solution 2 TBA
09:00 - 09:05 Clinical and R&D Representative Solution 3 TBA
09:05 - 09:10 Clinical and R&D Representative Solution 4 TBA
09:10 - 09:15 Clinical and R&D Representative Solution 5 TBA
09:15 - 09:20 Q&A, Voting and Discussion All
09:20 - 09:27 Solution Robin Heijmen (Nijmegen)
09:27 - 09:35 Case Summary All
09:35 –10:45
CASE 2: Aortic Arch Aneurysm- Incidential Finding, Maximum Diameter of 54mm, Isolated
Left Vertebral Artery Offspring
Chair: Martin Czerny (Freiburg), Jürg Schmidli (Bern)
CommitteeExperts: Luca Bertoglio (Brescia), Andreas Martens (Oldenburg)
09:35 - 09:45 Case Presentation Stephan Haulon (Paris)
09:45 - 09:50 Imaging Analysis Adrian Huber (Lucerne)
09:50 - 09:55 Guideline Comment Santi Trimarchi (Milan)
09:55 - 10:00 Q&A, Voting and Discussion All
10:00 - 10:05 Clinical and R&D Representative Solution 1 TBA
10:05 - 10:10 Clinical and R&D Representative Solution 2 TBA
10:10 - 10:15 Clinical and R&D Representative Solution 3 TBA
10:15 - 10:20 Clinical and R&D Representative Solution 4 TBA
10:20 - 10:25 Clinical and R&D Representative Solution 5 TBA
10:25 - 10:30 Q&A, Voting and Discussion All
10:30 - 10:37 Solution Stephan Haulon (Paris)
10:37 - 10:45 Case Summary All
RefreshmentBreak
11:05 –12:15
CASE 3: Post Dissection Aneurysmal Formation After Previous Type A Repair With Moderate
Aortic Insufficiency and 40mm Sinus of Valsalva Diameter, Potential Suitability for Branched
Endovascular Aortic Arch Repair
Chair: Luca Bertoglio (Brescia), Andreas Martens (Oldenburg)
CommitteeExperts: Sven Hauck (Vienna), Maximilian Kreibich (Freiburg)
11:05 - 11:15 Case Presentation Geert-Willem Schurink (Maastricht)
11:15 - 11:20 Imaging Analysis Adrian Huber (Lucerne)
11:20 - 11:25 Guideline Comment Tim Berger (Freiburg)
11:25 - 11:30 Q&A, Voting and Discussion All
11:30 - 11:35 Clinical and R&D Representative Solution 1 TBA
11:35 - 11:40 Clinical and R&D Representative Solution 2 TBA
11:40 - 11:45 Clinical and R&D Representative Solution 3 TBA
11:45 - 11:50 Clinical and R&D Representative Solution 4 TBA
11:50 - 11:55 Clinical and R&D Representative Solution 5 TBA
11:55 - 12:00 Q&A, Voting and Discussion All
12:00 - 12:07 Solution Geert-Willem Schurink (Maastricht)
12:07 - 12:15 Case Summary All
Lunch Break
12:45 - 13:30 Lunch Symposium TBA
13:30–14:40
CASE 4: Uncomplicated non-A-non-B Aortic Dissection
Chair: Stefano Benussi (Brescia), Julia Dumfarth (Innsbruck)
CommitteeExperts: Tilo Kölbel (Hamburg), Florian Schönhoff (Bern)
13:30 - 13:40 Case Presentation Tim Berger (Freiburg)
13:40 - 13:45 Imaging Analysis Adrian Huber (Lucerne)
13:45 - 13:50 Guideline Comment Bartosz Rylski (Stuttgart)
13:50 - 13:55 Q&A, Voting and Discussion All
13:55 - 14:00 Clinical and R&D Representative Solution 1 TBA
14:00 - 14:05 Clinical and R&D Representative Solution 2 TBA
14:05 - 14:10 Clinical and R&D Representative Solution 3 TBA
14:10 - 14:15 Clinical and R&D Representative Solution 4 TBA
14:15 - 14:20 Clinical and R&D Representative Solution 5 TBA
14:20 - 14:25 Q&A, Voting and Discussion All
14:25 - 14:32 Solution Tim Berger (Freiburg)
14:32 - 14:40 Case Summary All
Program Friday, 25th
October 2024
14:40 – 16:10
CBL– Complication Cases
Chair: TBA
CommitteeExperts: TBA
14:40 - 14:55 TBA TBA
14:55 - 15:10 TBA TBA
15:10 - 15:25 TBA TBA
15:25 - 15:40 TBA TBA
15:40 - 15:55 TBA TBA
15:55 - 16:10 TBA TBA
RefreshmentBreak
16:30 –17:40
CASE 5: Post Dissection Aneurysmal Formation with Very Small True Lumen
Chair: Christian Etz (Rostock), Tilo Kölbel (Hamburg)
CommitteeExperts: Joe Bavaria (Philadelphia), Omer Dzemali (Zurich)
16:30 - 16:40 Case Presentation Vladimir Makaloski (Bern)
16:40 - 16:45 Imaging Analysis Adrian Huber (Lucerne)
16:45 - 16:50 Guideline Comment Gabriele Piffaretti (Varese)
16:50 - 16:55 Q&A, Voting and Discussion All
16:55 - 17:00 Clinical and R&D Representative Solution 1 TBA
17:00 - 17:05 Clinical and R&D Representative Solution 2 TBA
17:05 - 17:10 Clinical and R&D Representative Solution 3 TBA
17:10 - 17:15 Clinical and R&D Representative Solution 4 TBA
17:15 - 17:20 Clinical and R&D Representative Solution 5 TBA
17:20 - 17:25 Q&A, Voting and Discussion All
17:25 - 17:32 Solution Vladimir Makaloski (Bern)
17:32 - 17:40 Case Summary All
17:40 –18:50
CASE 6: Type 3.5 Post Dissection Aneurysmal Formation After Proximal Full Fix
Chair: Luca di Marco (Bologna), Sabine Wipper (Innsbruck)
CommitteeExperts: Aung Oo (London), Nikolaos Tsilimparis (Munich)
17:40 - 17:50 Case Presentation Luca Bertoglio (Brescia)
17:50 - 17:55 Imaging Analysis Adrian Huber (Lucerne)
17:55 - 18:00 Guideline Comment Florian Schönhoff (Bern)
18:00 - 18:05 Q&A, Voting and Discussion All
18:05 - 18:10 Clinical and R&D Representative Solution 1 TBA
18:10 - 18:15 Clinical and R&D Representative Solution 2 TBA
18:15 - 18:20 Clinical and R&D Representative Solution 3 TBA
18:20 - 18:25 Clinical and R&D Representative Solution 4 TBA
18:25 - 18:30 Clinical and R&D Representative Solution 5 TBA
18:30 - 18:35 Q&A, Voting and Discussion All
18:35 - 18:42 Solution Luca Bertoglio (Brescia)
18:42 - 18:50 Case Summary All
18:50 –19:00 Closing Remarks Day 1
Program Friday, 25th
October 2024
08:15 –09:25
CASE 7: Type II TAAA
Chair: Michael Jacobs (Maastricht), Eric Verhoeven (Nuremberg)
CommitteeExperts: Roberto Chiesa (Milan), Davide Pacini (Bologna)
08:15 - 08:25 Case Presentation Martin Grabenwöger (Vienna)
08:25 - 08:30 Imaging Analysis Adrian Huber (Lucerne)
08:30 - 08:35 Guideline Comment Konstantinos Tsagakis (Essen)
08:35 - 08:40 Q&A, Voting and Discussion All
08:40 - 08:45 Clinical and R&D Representative Solution 1 TBA
08:45 - 08:50 Clinical and R&D Representative Solution 2 TBA
08:50 - 08:55 Clinical and R&D Representative Solution 3 TBA
08:55 - 09:00 Clinical and R&D Representative Solution 4 TBA
09:00 - 09:05 Clinical and R&D Representative Solution 5 TBA
09:05 - 09:10 Q&A, Voting and Discussion All
09:10 - 09:17 Solution Martin Grabenwöger (Vienna)
09:17 - 09:25 Case Summary All
09:25 – 10:25
Special GuestLecture
Chair: TBA
CommitteeExperts: TBA
09:25 - 09:45 Disaster Prevention in Endovascular Aortic Treatment Stephan Haulon (Paris)
09:45 - 10:05 Device Malfunction TBA
10:05 - 10:25 Artificial Intelligence or New Developments in Robotics Roland Siegwart (Zurich), ETH
RefreshmentBreak
10:45 – 12:05
Young Faculty Session -(CBL) E-learning Cases Session – Presentation of 4 AA Library
Cases
Chair: Julia Dumfarth (Innsbruck), Mario Lescan (Freiburg)
CommitteeExperts: Carlota Fernandez Prendes (Munich), Ryan Melo (Lisbon)
10:45 - 11:05 TBA TBA
11:05 - 11:25 TBA TBA
11:25 - 11:45 TBA TBA
11:45 - 12:05 TBA TBA
Program Saturday, 26th
October 2024
Program Saturday, 26th
October 2024
12:05 –13:15
CASE 8: Pararenal AAA
Chair: Vladimir Makaloski (Bern), Aleksander Zimmermann (Zurich)
CommitteeExperts: Pekka Aho (Helsinki), Michael Jenkins (London)
12:05 - 12:15 Case Presentation Eric Verhoeven (Nuremberg)
12:15 - 12:20 Imaging Analysis Adrian Huber (Lucerne)
12:20 - 12:25 Guideline Comment Mario Lescan (Freiburg)
12:25 - 12:30 Q&A, Voting and Discussion All
12:30 - 12:35 Clinical and R&D Representative Solution 1 TBA
12:35 - 12:40 Clinical and R&D Representative Solution 2 TBA
12:40 - 12:45 Clinical and R&D Representative Solution 3 TBA
12:45 - 12:50 Clinical and R&D Representative Solution 4 TBA
12:50 - 12:55 Clinical and R&D Representative Solution 5 TBA
12:55 - 13:00 Q&A, Voting and Discussion All
13:00 - 13:07 Solution Eric Verhoeven (Nuremberg)
13:07 - 13:15 Case Summary All
Lunch Break
13:45 - 14:30 Lunch Symposium TBA
14:30 –15:40
CASE 9: Common and Internal Iliac Artery Aneurysm After TAAA Repair
Chair: Luca Bertoglio (Brescia), Mario Lescan (Freiburg)
CommitteeExperts: Ryan Melo (Lisbon), Christoph Nienaber (London)
14:30 - 14:40 Case Presentation Tim Resch (Copenhagen)
14:40 - 14:45 Imaging Analysis Adrian Huber (Lucerne)
14:45 - 14:50 Guideline Comment TBA
14:50 - 14:55 Q&A, Voting and Discussion All
14:55 - 15:00 Clinical and R&D Representative Solution 1 TBA
15:00 - 15:05 Clinical and R&D Representative Solution 2 TBA
15:05 - 15:10 Clinical and R&D Representative Solution 3 TBA
15:10 - 15:15 Clinical and R&D Representative Solution 4 TBA
15:15 - 15:20 Clinical and R&D Representative Solution 5 TBA
15:20 - 15:25 Q&A, Voting and Discussion All
15:25 - 15:32 Solution Tim Resch (Copenhagen)
15:32 - 15:40 Case Summary All
15:40 – 15:50 Feedback & Closing Remarks Day 2

More Related Content

Similar to CBL Seminar 2024_Preliminary Program.pdf

GIN conference and Cochrane Colloquium 2018
GIN conference and Cochrane Colloquium 2018GIN conference and Cochrane Colloquium 2018
GIN conference and Cochrane Colloquium 2018
CEBaP_rkv
 
Biomaterials sample program 2023.pdf
Biomaterials sample program 2023.pdfBiomaterials sample program 2023.pdf
Biomaterials sample program 2023.pdf
biomaterialsAmy
 
2nd European Conference on Clinical Research
2nd European Conference on Clinical Research2nd European Conference on Clinical Research
2nd European Conference on Clinical Research
Market iT
 
Program final conference ViPi ATLEC symposium 04/12/2013
Program final conference ViPi ATLEC symposium 04/12/2013Program final conference ViPi ATLEC symposium 04/12/2013
Program final conference ViPi ATLEC symposium 04/12/2013
Karel Van Isacker
 
Programa Científico ISBD 2014
Programa Científico ISBD 2014Programa Científico ISBD 2014
Programa Científico ISBD 2014
infobipolar
 
Pp 13 johali presentation in program iccec aangepast 4
Pp 13 johali presentation in program iccec aangepast 4Pp 13 johali presentation in program iccec aangepast 4
Pp 13 johali presentation in program iccec aangepast 4
Eisa Johali
 
REG Interstitial Lung Disease Working Group Meeting
REG Interstitial Lung Disease Working Group MeetingREG Interstitial Lung Disease Working Group Meeting
REG Interstitial Lung Disease Working Group Meeting
Zoe Mitchell
 
141013_MAR agenda invitation program Mar2015_v1
141013_MAR agenda invitation program Mar2015_v1141013_MAR agenda invitation program Mar2015_v1
141013_MAR agenda invitation program Mar2015_v1
Popa Daniel
 
Brocher symposium, july 5-7, 2015
Brocher symposium, july 5-7, 2015Brocher symposium, july 5-7, 2015
Brocher symposium, july 5-7, 2015
Fondation Brocher
 
ITS Food 2024_AgendJBKJASFBJKLG..BJAJB.JGK.pdf
ITS Food 2024_AgendJBKJASFBJKLG..BJAJB.JGK.pdfITS Food 2024_AgendJBKJASFBJKLG..BJAJB.JGK.pdf
ITS Food 2024_AgendJBKJASFBJKLG..BJAJB.JGK.pdf
HabtamuFekadu3
 
Ageing creatively. seminar 20th march
Ageing creatively. seminar 20th marchAgeing creatively. seminar 20th march
Ageing creatively. seminar 20th march
Netwell Centre
 
SRA annual conference programme 2013
SRA annual conference programme 2013SRA annual conference programme 2013
SRA annual conference programme 2013
TheSRAOrg
 

Similar to CBL Seminar 2024_Preliminary Program.pdf (12)

GIN conference and Cochrane Colloquium 2018
GIN conference and Cochrane Colloquium 2018GIN conference and Cochrane Colloquium 2018
GIN conference and Cochrane Colloquium 2018
 
Biomaterials sample program 2023.pdf
Biomaterials sample program 2023.pdfBiomaterials sample program 2023.pdf
Biomaterials sample program 2023.pdf
 
2nd European Conference on Clinical Research
2nd European Conference on Clinical Research2nd European Conference on Clinical Research
2nd European Conference on Clinical Research
 
Program final conference ViPi ATLEC symposium 04/12/2013
Program final conference ViPi ATLEC symposium 04/12/2013Program final conference ViPi ATLEC symposium 04/12/2013
Program final conference ViPi ATLEC symposium 04/12/2013
 
Programa Científico ISBD 2014
Programa Científico ISBD 2014Programa Científico ISBD 2014
Programa Científico ISBD 2014
 
Pp 13 johali presentation in program iccec aangepast 4
Pp 13 johali presentation in program iccec aangepast 4Pp 13 johali presentation in program iccec aangepast 4
Pp 13 johali presentation in program iccec aangepast 4
 
REG Interstitial Lung Disease Working Group Meeting
REG Interstitial Lung Disease Working Group MeetingREG Interstitial Lung Disease Working Group Meeting
REG Interstitial Lung Disease Working Group Meeting
 
141013_MAR agenda invitation program Mar2015_v1
141013_MAR agenda invitation program Mar2015_v1141013_MAR agenda invitation program Mar2015_v1
141013_MAR agenda invitation program Mar2015_v1
 
Brocher symposium, july 5-7, 2015
Brocher symposium, july 5-7, 2015Brocher symposium, july 5-7, 2015
Brocher symposium, july 5-7, 2015
 
ITS Food 2024_AgendJBKJASFBJKLG..BJAJB.JGK.pdf
ITS Food 2024_AgendJBKJASFBJKLG..BJAJB.JGK.pdfITS Food 2024_AgendJBKJASFBJKLG..BJAJB.JGK.pdf
ITS Food 2024_AgendJBKJASFBJKLG..BJAJB.JGK.pdf
 
Ageing creatively. seminar 20th march
Ageing creatively. seminar 20th marchAgeing creatively. seminar 20th march
Ageing creatively. seminar 20th march
 
SRA annual conference programme 2013
SRA annual conference programme 2013SRA annual conference programme 2013
SRA annual conference programme 2013
 

Recently uploaded

Recognizing and Managing Bacterial Vaginosis.pptx
Recognizing and Managing Bacterial Vaginosis.pptxRecognizing and Managing Bacterial Vaginosis.pptx
Recognizing and Managing Bacterial Vaginosis.pptx
FFragrant
 
Interpretation of ECG - Cardiac Arrhythmias
Interpretation of ECG - Cardiac ArrhythmiasInterpretation of ECG - Cardiac Arrhythmias
Interpretation of ECG - Cardiac Arrhythmias
MedicoseAcademics
 
Amygdala Medi-Trivia Quiz (Prelims) | FAQ 2024
Amygdala Medi-Trivia Quiz (Prelims) | FAQ 2024Amygdala Medi-Trivia Quiz (Prelims) | FAQ 2024
Amygdala Medi-Trivia Quiz (Prelims) | FAQ 2024
Anindya Das Adhikary
 
Article - Design and evaluation of novel inhibitors for the treatment of clea...
Article - Design and evaluation of novel inhibitors for the treatment of clea...Article - Design and evaluation of novel inhibitors for the treatment of clea...
Article - Design and evaluation of novel inhibitors for the treatment of clea...
Trustlife
 
Text book of comprehensive Medical Surgical Nursing
Text book of comprehensive Medical Surgical NursingText book of comprehensive Medical Surgical Nursing
Text book of comprehensive Medical Surgical Nursing
BP KOIRALA INSTITUTE OF HELATH SCIENCS,, NEPAL
 
Drug Repurposing for Parasitic Diseases.pptx
Drug Repurposing for Parasitic Diseases.pptxDrug Repurposing for Parasitic Diseases.pptx
Drug Repurposing for Parasitic Diseases.pptx
drebrahiim
 
Pharmacological Management of Hypertension: New Drugs and Mechanisms
Pharmacological Management of Hypertension: New Drugs and MechanismsPharmacological Management of Hypertension: New Drugs and Mechanisms
Pharmacological Management of Hypertension: New Drugs and Mechanisms
Medwin Publishers
 
vaginal thrush presentation by Dr. Rewas Ali
vaginal thrush presentation by Dr. Rewas Alivaginal thrush presentation by Dr. Rewas Ali
vaginal thrush presentation by Dr. Rewas Ali
RewAs ALI
 
medical law and ethics presentation .ppt
medical law and ethics presentation .pptmedical law and ethics presentation .ppt
medical law and ethics presentation .ppt
PseudoPocket
 
Gestational Trophoblastic Disease( GTD)- Molar pregnancy, Gestational Trophob...
Gestational Trophoblastic Disease( GTD)- Molar pregnancy, Gestational Trophob...Gestational Trophoblastic Disease( GTD)- Molar pregnancy, Gestational Trophob...
Gestational Trophoblastic Disease( GTD)- Molar pregnancy, Gestational Trophob...
Dr.Nishant Janu
 
symblephoron types etiology management.pptx
symblephoron types etiology management.pptxsymblephoron types etiology management.pptx
symblephoron types etiology management.pptx
mohammadsumairah
 
Safeguarding Reproductive Health- Preventing Fallopian Tube Blockage After a ...
Safeguarding Reproductive Health- Preventing Fallopian Tube Blockage After a ...Safeguarding Reproductive Health- Preventing Fallopian Tube Blockage After a ...
Safeguarding Reproductive Health- Preventing Fallopian Tube Blockage After a ...
FFragrant
 
Text Book of Nursing Concepts - Fundamental of Nursing
Text Book of Nursing Concepts - Fundamental of NursingText Book of Nursing Concepts - Fundamental of Nursing
Text Book of Nursing Concepts - Fundamental of Nursing
BP KOIRALA INSTITUTE OF HELATH SCIENCS,, NEPAL
 
Text Book of Operation Theater Nursing OT Nursing
Text Book of Operation Theater Nursing OT NursingText Book of Operation Theater Nursing OT Nursing
Text Book of Operation Theater Nursing OT Nursing
BP KOIRALA INSTITUTE OF HELATH SCIENCS,, NEPAL
 
2nd week of Human development .embryology
2nd week of Human development .embryology2nd week of Human development .embryology
2nd week of Human development .embryology
Mithilesh Chaurasia
 
Text Book of Critical Care Nursing ICU NURSING
Text Book of Critical Care Nursing  ICU NURSINGText Book of Critical Care Nursing  ICU NURSING
Text Book of Critical Care Nursing ICU NURSING
BP KOIRALA INSTITUTE OF HELATH SCIENCS,, NEPAL
 
Top 10 Habits for Longevity [Biohacker Summit 2024]
Top 10 Habits for Longevity [Biohacker Summit 2024]Top 10 Habits for Longevity [Biohacker Summit 2024]
Top 10 Habits for Longevity [Biohacker Summit 2024]
Olli Sovijärvi
 
THE REVIEW OF THE ENCYCLOPEDIA OF PURE MATERIA MEDICA.BHMS.MATERIA MEDICA.HOM...
THE REVIEW OF THE ENCYCLOPEDIA OF PURE MATERIA MEDICA.BHMS.MATERIA MEDICA.HOM...THE REVIEW OF THE ENCYCLOPEDIA OF PURE MATERIA MEDICA.BHMS.MATERIA MEDICA.HOM...
THE REVIEW OF THE ENCYCLOPEDIA OF PURE MATERIA MEDICA.BHMS.MATERIA MEDICA.HOM...
DRPREETHIJAMESP
 
Hemodialysis: Chapter 9, Arteriovenous Fistula and Graft: Basics, Creation, U...
Hemodialysis: Chapter 9, Arteriovenous Fistula and Graft: Basics, Creation, U...Hemodialysis: Chapter 9, Arteriovenous Fistula and Graft: Basics, Creation, U...
Hemodialysis: Chapter 9, Arteriovenous Fistula and Graft: Basics, Creation, U...
NephroTube - Dr.Gawad
 
Types of Hypoxia, Hypercapnia, and Cyanosis
Types of Hypoxia, Hypercapnia, and CyanosisTypes of Hypoxia, Hypercapnia, and Cyanosis
Types of Hypoxia, Hypercapnia, and Cyanosis
MedicoseAcademics
 

Recently uploaded (20)

Recognizing and Managing Bacterial Vaginosis.pptx
Recognizing and Managing Bacterial Vaginosis.pptxRecognizing and Managing Bacterial Vaginosis.pptx
Recognizing and Managing Bacterial Vaginosis.pptx
 
Interpretation of ECG - Cardiac Arrhythmias
Interpretation of ECG - Cardiac ArrhythmiasInterpretation of ECG - Cardiac Arrhythmias
Interpretation of ECG - Cardiac Arrhythmias
 
Amygdala Medi-Trivia Quiz (Prelims) | FAQ 2024
Amygdala Medi-Trivia Quiz (Prelims) | FAQ 2024Amygdala Medi-Trivia Quiz (Prelims) | FAQ 2024
Amygdala Medi-Trivia Quiz (Prelims) | FAQ 2024
 
Article - Design and evaluation of novel inhibitors for the treatment of clea...
Article - Design and evaluation of novel inhibitors for the treatment of clea...Article - Design and evaluation of novel inhibitors for the treatment of clea...
Article - Design and evaluation of novel inhibitors for the treatment of clea...
 
Text book of comprehensive Medical Surgical Nursing
Text book of comprehensive Medical Surgical NursingText book of comprehensive Medical Surgical Nursing
Text book of comprehensive Medical Surgical Nursing
 
Drug Repurposing for Parasitic Diseases.pptx
Drug Repurposing for Parasitic Diseases.pptxDrug Repurposing for Parasitic Diseases.pptx
Drug Repurposing for Parasitic Diseases.pptx
 
Pharmacological Management of Hypertension: New Drugs and Mechanisms
Pharmacological Management of Hypertension: New Drugs and MechanismsPharmacological Management of Hypertension: New Drugs and Mechanisms
Pharmacological Management of Hypertension: New Drugs and Mechanisms
 
vaginal thrush presentation by Dr. Rewas Ali
vaginal thrush presentation by Dr. Rewas Alivaginal thrush presentation by Dr. Rewas Ali
vaginal thrush presentation by Dr. Rewas Ali
 
medical law and ethics presentation .ppt
medical law and ethics presentation .pptmedical law and ethics presentation .ppt
medical law and ethics presentation .ppt
 
Gestational Trophoblastic Disease( GTD)- Molar pregnancy, Gestational Trophob...
Gestational Trophoblastic Disease( GTD)- Molar pregnancy, Gestational Trophob...Gestational Trophoblastic Disease( GTD)- Molar pregnancy, Gestational Trophob...
Gestational Trophoblastic Disease( GTD)- Molar pregnancy, Gestational Trophob...
 
symblephoron types etiology management.pptx
symblephoron types etiology management.pptxsymblephoron types etiology management.pptx
symblephoron types etiology management.pptx
 
Safeguarding Reproductive Health- Preventing Fallopian Tube Blockage After a ...
Safeguarding Reproductive Health- Preventing Fallopian Tube Blockage After a ...Safeguarding Reproductive Health- Preventing Fallopian Tube Blockage After a ...
Safeguarding Reproductive Health- Preventing Fallopian Tube Blockage After a ...
 
Text Book of Nursing Concepts - Fundamental of Nursing
Text Book of Nursing Concepts - Fundamental of NursingText Book of Nursing Concepts - Fundamental of Nursing
Text Book of Nursing Concepts - Fundamental of Nursing
 
Text Book of Operation Theater Nursing OT Nursing
Text Book of Operation Theater Nursing OT NursingText Book of Operation Theater Nursing OT Nursing
Text Book of Operation Theater Nursing OT Nursing
 
2nd week of Human development .embryology
2nd week of Human development .embryology2nd week of Human development .embryology
2nd week of Human development .embryology
 
Text Book of Critical Care Nursing ICU NURSING
Text Book of Critical Care Nursing  ICU NURSINGText Book of Critical Care Nursing  ICU NURSING
Text Book of Critical Care Nursing ICU NURSING
 
Top 10 Habits for Longevity [Biohacker Summit 2024]
Top 10 Habits for Longevity [Biohacker Summit 2024]Top 10 Habits for Longevity [Biohacker Summit 2024]
Top 10 Habits for Longevity [Biohacker Summit 2024]
 
THE REVIEW OF THE ENCYCLOPEDIA OF PURE MATERIA MEDICA.BHMS.MATERIA MEDICA.HOM...
THE REVIEW OF THE ENCYCLOPEDIA OF PURE MATERIA MEDICA.BHMS.MATERIA MEDICA.HOM...THE REVIEW OF THE ENCYCLOPEDIA OF PURE MATERIA MEDICA.BHMS.MATERIA MEDICA.HOM...
THE REVIEW OF THE ENCYCLOPEDIA OF PURE MATERIA MEDICA.BHMS.MATERIA MEDICA.HOM...
 
Hemodialysis: Chapter 9, Arteriovenous Fistula and Graft: Basics, Creation, U...
Hemodialysis: Chapter 9, Arteriovenous Fistula and Graft: Basics, Creation, U...Hemodialysis: Chapter 9, Arteriovenous Fistula and Graft: Basics, Creation, U...
Hemodialysis: Chapter 9, Arteriovenous Fistula and Graft: Basics, Creation, U...
 
Types of Hypoxia, Hypercapnia, and Cyanosis
Types of Hypoxia, Hypercapnia, and CyanosisTypes of Hypoxia, Hypercapnia, and Cyanosis
Types of Hypoxia, Hypercapnia, and Cyanosis
 

CBL Seminar 2024_Preliminary Program.pdf

  • 2. General Information Date 25 – 26 October 2024 Venue Hilton Zurich Airport Hohenbuehlstrasse 10 8152 Opfikon Switzerland Learning objectives Understanding the disease forms the basis, being familiar with the treatment options available, enlarges the armamentarium and being able to implement them into clinical practice provides the freedom and the flexibility to offer sustainable personalized solutions to treat patients with acute and chronic aortic pathology in an aortic team. During the CBL Seminar in Zurich, you will be taken on an intensive expert interaction journey through treatment concept of defined locations of the organ Aorta by addressing both open surgery and endovascular therapy. Course Directors Martin Czerny, Freiburg, Germany Jürg Schmidli, Bern, Switzerland Seminar by Aortic Association www.aorticassociation.org E-Mail: info@aorticassociation.com Logistics and Organization Education Event Impact GmbH www.ee-impact.org Tel.: +41 79 247 98 75 E-Mail: info@ee-impact.org
  • 3. Program Friday, 25th October 2024 Registration and Welcome Coffee 08:15 - 08:25 Introduction, Course Targets Martin Czerny (Freiburg), Jürg Schmidli (Bern) 08:25 –09:35 CASE 1: Sinus of Valsalva Aneurysm- Bicuspid Aortic Valve Aortopathy, Diameter at Brachiocephalic Trunk 43mm, Small PAU-Like Structure in Zone 3, Regular Findings in Downstream Segments Chair: Martin Czerny (Freiburg), Jürg Schmidli (Bern) CommitteeExperts: Joseph E. Bavaria (Philadelphia), Matthias Siepe (Bern) 08:25 - 08:35 Case Presentation Robin Heijmen (Nijmegen) 08:35 - 08:40 Imaging Analysis Adrian Huber (Lucerne) 08:40 - 08:45 Guideline Comment Alessandro Della Corte (Naples) 08:45 - 08:50 Q&A, Voting and Discussion All 08:50 - 08:55 Clinical and R&D Representative Solution 1 TBA 08:55 - 09:00 Clinical and R&D Representative Solution 2 TBA 09:00 - 09:05 Clinical and R&D Representative Solution 3 TBA 09:05 - 09:10 Clinical and R&D Representative Solution 4 TBA 09:10 - 09:15 Clinical and R&D Representative Solution 5 TBA 09:15 - 09:20 Q&A, Voting and Discussion All 09:20 - 09:27 Solution Robin Heijmen (Nijmegen) 09:27 - 09:35 Case Summary All 09:35 –10:45 CASE 2: Aortic Arch Aneurysm- Incidential Finding, Maximum Diameter of 54mm, Isolated Left Vertebral Artery Offspring Chair: Martin Czerny (Freiburg), Jürg Schmidli (Bern) CommitteeExperts: Luca Bertoglio (Brescia), Andreas Martens (Oldenburg) 09:35 - 09:45 Case Presentation Stephan Haulon (Paris) 09:45 - 09:50 Imaging Analysis Adrian Huber (Lucerne) 09:50 - 09:55 Guideline Comment Santi Trimarchi (Milan) 09:55 - 10:00 Q&A, Voting and Discussion All 10:00 - 10:05 Clinical and R&D Representative Solution 1 TBA 10:05 - 10:10 Clinical and R&D Representative Solution 2 TBA 10:10 - 10:15 Clinical and R&D Representative Solution 3 TBA 10:15 - 10:20 Clinical and R&D Representative Solution 4 TBA 10:20 - 10:25 Clinical and R&D Representative Solution 5 TBA 10:25 - 10:30 Q&A, Voting and Discussion All 10:30 - 10:37 Solution Stephan Haulon (Paris) 10:37 - 10:45 Case Summary All RefreshmentBreak
  • 4. 11:05 –12:15 CASE 3: Post Dissection Aneurysmal Formation After Previous Type A Repair With Moderate Aortic Insufficiency and 40mm Sinus of Valsalva Diameter, Potential Suitability for Branched Endovascular Aortic Arch Repair Chair: Luca Bertoglio (Brescia), Andreas Martens (Oldenburg) CommitteeExperts: Sven Hauck (Vienna), Maximilian Kreibich (Freiburg) 11:05 - 11:15 Case Presentation Geert-Willem Schurink (Maastricht) 11:15 - 11:20 Imaging Analysis Adrian Huber (Lucerne) 11:20 - 11:25 Guideline Comment Tim Berger (Freiburg) 11:25 - 11:30 Q&A, Voting and Discussion All 11:30 - 11:35 Clinical and R&D Representative Solution 1 TBA 11:35 - 11:40 Clinical and R&D Representative Solution 2 TBA 11:40 - 11:45 Clinical and R&D Representative Solution 3 TBA 11:45 - 11:50 Clinical and R&D Representative Solution 4 TBA 11:50 - 11:55 Clinical and R&D Representative Solution 5 TBA 11:55 - 12:00 Q&A, Voting and Discussion All 12:00 - 12:07 Solution Geert-Willem Schurink (Maastricht) 12:07 - 12:15 Case Summary All Lunch Break 12:45 - 13:30 Lunch Symposium TBA 13:30–14:40 CASE 4: Uncomplicated non-A-non-B Aortic Dissection Chair: Stefano Benussi (Brescia), Julia Dumfarth (Innsbruck) CommitteeExperts: Tilo Kölbel (Hamburg), Florian Schönhoff (Bern) 13:30 - 13:40 Case Presentation Tim Berger (Freiburg) 13:40 - 13:45 Imaging Analysis Adrian Huber (Lucerne) 13:45 - 13:50 Guideline Comment Bartosz Rylski (Stuttgart) 13:50 - 13:55 Q&A, Voting and Discussion All 13:55 - 14:00 Clinical and R&D Representative Solution 1 TBA 14:00 - 14:05 Clinical and R&D Representative Solution 2 TBA 14:05 - 14:10 Clinical and R&D Representative Solution 3 TBA 14:10 - 14:15 Clinical and R&D Representative Solution 4 TBA 14:15 - 14:20 Clinical and R&D Representative Solution 5 TBA 14:20 - 14:25 Q&A, Voting and Discussion All 14:25 - 14:32 Solution Tim Berger (Freiburg) 14:32 - 14:40 Case Summary All Program Friday, 25th October 2024
  • 5. 14:40 – 16:10 CBL– Complication Cases Chair: TBA CommitteeExperts: TBA 14:40 - 14:55 TBA TBA 14:55 - 15:10 TBA TBA 15:10 - 15:25 TBA TBA 15:25 - 15:40 TBA TBA 15:40 - 15:55 TBA TBA 15:55 - 16:10 TBA TBA RefreshmentBreak 16:30 –17:40 CASE 5: Post Dissection Aneurysmal Formation with Very Small True Lumen Chair: Christian Etz (Rostock), Tilo Kölbel (Hamburg) CommitteeExperts: Joe Bavaria (Philadelphia), Omer Dzemali (Zurich) 16:30 - 16:40 Case Presentation Vladimir Makaloski (Bern) 16:40 - 16:45 Imaging Analysis Adrian Huber (Lucerne) 16:45 - 16:50 Guideline Comment Gabriele Piffaretti (Varese) 16:50 - 16:55 Q&A, Voting and Discussion All 16:55 - 17:00 Clinical and R&D Representative Solution 1 TBA 17:00 - 17:05 Clinical and R&D Representative Solution 2 TBA 17:05 - 17:10 Clinical and R&D Representative Solution 3 TBA 17:10 - 17:15 Clinical and R&D Representative Solution 4 TBA 17:15 - 17:20 Clinical and R&D Representative Solution 5 TBA 17:20 - 17:25 Q&A, Voting and Discussion All 17:25 - 17:32 Solution Vladimir Makaloski (Bern) 17:32 - 17:40 Case Summary All 17:40 –18:50 CASE 6: Type 3.5 Post Dissection Aneurysmal Formation After Proximal Full Fix Chair: Luca di Marco (Bologna), Sabine Wipper (Innsbruck) CommitteeExperts: Aung Oo (London), Nikolaos Tsilimparis (Munich) 17:40 - 17:50 Case Presentation Luca Bertoglio (Brescia) 17:50 - 17:55 Imaging Analysis Adrian Huber (Lucerne) 17:55 - 18:00 Guideline Comment Florian Schönhoff (Bern) 18:00 - 18:05 Q&A, Voting and Discussion All 18:05 - 18:10 Clinical and R&D Representative Solution 1 TBA 18:10 - 18:15 Clinical and R&D Representative Solution 2 TBA 18:15 - 18:20 Clinical and R&D Representative Solution 3 TBA 18:20 - 18:25 Clinical and R&D Representative Solution 4 TBA 18:25 - 18:30 Clinical and R&D Representative Solution 5 TBA 18:30 - 18:35 Q&A, Voting and Discussion All 18:35 - 18:42 Solution Luca Bertoglio (Brescia) 18:42 - 18:50 Case Summary All 18:50 –19:00 Closing Remarks Day 1 Program Friday, 25th October 2024
  • 6. 08:15 –09:25 CASE 7: Type II TAAA Chair: Michael Jacobs (Maastricht), Eric Verhoeven (Nuremberg) CommitteeExperts: Roberto Chiesa (Milan), Davide Pacini (Bologna) 08:15 - 08:25 Case Presentation Martin Grabenwöger (Vienna) 08:25 - 08:30 Imaging Analysis Adrian Huber (Lucerne) 08:30 - 08:35 Guideline Comment Konstantinos Tsagakis (Essen) 08:35 - 08:40 Q&A, Voting and Discussion All 08:40 - 08:45 Clinical and R&D Representative Solution 1 TBA 08:45 - 08:50 Clinical and R&D Representative Solution 2 TBA 08:50 - 08:55 Clinical and R&D Representative Solution 3 TBA 08:55 - 09:00 Clinical and R&D Representative Solution 4 TBA 09:00 - 09:05 Clinical and R&D Representative Solution 5 TBA 09:05 - 09:10 Q&A, Voting and Discussion All 09:10 - 09:17 Solution Martin Grabenwöger (Vienna) 09:17 - 09:25 Case Summary All 09:25 – 10:25 Special GuestLecture Chair: TBA CommitteeExperts: TBA 09:25 - 09:45 Disaster Prevention in Endovascular Aortic Treatment Stephan Haulon (Paris) 09:45 - 10:05 Device Malfunction TBA 10:05 - 10:25 Artificial Intelligence or New Developments in Robotics Roland Siegwart (Zurich), ETH RefreshmentBreak 10:45 – 12:05 Young Faculty Session -(CBL) E-learning Cases Session – Presentation of 4 AA Library Cases Chair: Julia Dumfarth (Innsbruck), Mario Lescan (Freiburg) CommitteeExperts: Carlota Fernandez Prendes (Munich), Ryan Melo (Lisbon) 10:45 - 11:05 TBA TBA 11:05 - 11:25 TBA TBA 11:25 - 11:45 TBA TBA 11:45 - 12:05 TBA TBA Program Saturday, 26th October 2024
  • 7. Program Saturday, 26th October 2024 12:05 –13:15 CASE 8: Pararenal AAA Chair: Vladimir Makaloski (Bern), Aleksander Zimmermann (Zurich) CommitteeExperts: Pekka Aho (Helsinki), Michael Jenkins (London) 12:05 - 12:15 Case Presentation Eric Verhoeven (Nuremberg) 12:15 - 12:20 Imaging Analysis Adrian Huber (Lucerne) 12:20 - 12:25 Guideline Comment Mario Lescan (Freiburg) 12:25 - 12:30 Q&A, Voting and Discussion All 12:30 - 12:35 Clinical and R&D Representative Solution 1 TBA 12:35 - 12:40 Clinical and R&D Representative Solution 2 TBA 12:40 - 12:45 Clinical and R&D Representative Solution 3 TBA 12:45 - 12:50 Clinical and R&D Representative Solution 4 TBA 12:50 - 12:55 Clinical and R&D Representative Solution 5 TBA 12:55 - 13:00 Q&A, Voting and Discussion All 13:00 - 13:07 Solution Eric Verhoeven (Nuremberg) 13:07 - 13:15 Case Summary All Lunch Break 13:45 - 14:30 Lunch Symposium TBA 14:30 –15:40 CASE 9: Common and Internal Iliac Artery Aneurysm After TAAA Repair Chair: Luca Bertoglio (Brescia), Mario Lescan (Freiburg) CommitteeExperts: Ryan Melo (Lisbon), Christoph Nienaber (London) 14:30 - 14:40 Case Presentation Tim Resch (Copenhagen) 14:40 - 14:45 Imaging Analysis Adrian Huber (Lucerne) 14:45 - 14:50 Guideline Comment TBA 14:50 - 14:55 Q&A, Voting and Discussion All 14:55 - 15:00 Clinical and R&D Representative Solution 1 TBA 15:00 - 15:05 Clinical and R&D Representative Solution 2 TBA 15:05 - 15:10 Clinical and R&D Representative Solution 3 TBA 15:10 - 15:15 Clinical and R&D Representative Solution 4 TBA 15:15 - 15:20 Clinical and R&D Representative Solution 5 TBA 15:20 - 15:25 Q&A, Voting and Discussion All 15:25 - 15:32 Solution Tim Resch (Copenhagen) 15:32 - 15:40 Case Summary All 15:40 – 15:50 Feedback & Closing Remarks Day 2